Performance Characteristics of a Non‐Fluorescent Aerolysin‐Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Assay for Simultaneous Evaluation of PNH Neutrophils and PNH Monocytes by Flow Cytometry, Following Published PNH Guidelines
Authors:
Open Access
- 13 June 2016
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 94 (2) , 257-263
Abstract
Background: CD157 has been recently reported as a useful glycosylphosphatidylinositol (GPI)‐linked marker for the detection of paroxysmal nocturnal hemoglobinuria (PNH) clones in patients with suspected paroxysmal nocturnal hemoglobinuria by flow cytometry as it targets both neutrophils and monocytes. The aim of this study is to test the feasibility of a non‐fluorescent aerolysin (FLAER) approach and propose an alternative for laboratories, where FLAER is not available.Methods: We validated a non‐FLAER‐based single‐tube, 6‐color assay targeting the GPI‐linked structures CD157, CD24, and CD14. We determined its performance characteristics on 20 PNH patient samples containing a variety of clone sizes and compared results with a previously validated FLAER‐based approach.Results: Coefficient of variation (CV) for intra‐/interassay precision analyses ranged from 0.1%/0.2% to 3.02%/7.58% for neutrophils and from 0.10%/0.3% to 5.39%/6.36% for monocytes. Coefficient of determination (r2) for linear regression analysis of PNH clones from 20 patients ranging from 0.06% to 99.7% was 0.99 in all cases, Wilcoxon ranks test showed no statistically significant differences (P > 0.05), Bland–Altman analysis demonstrated performance agreement with mean bias ranging from 0.06 to 0.2.Conclusion: Our results confirm very good performance characteristics for both intra‐ and interassay precision analyses, favorable correlation, and agreement between the FLAER and non‐FLAER‐based approaches, using the CD157 GPI marker. Our experience suggests that a rapid and cost‐effective simultaneous evaluation of PNH neutrophils and monocytes by flow cytometry without using FLAER is possible in areas where FLAER may not be widely available. © 2016 International Clinical Cytometry SocietyKeywords
This publication has 32 references indexed in Scilit:
- Use of a FLAER-Based WBC Assay in the Primary Screening of PNH ClonesAmerican Journal of Clinical Pathology, 2009
- Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuriaTransfusion, 2008
- Diagnosing PNH with FLAER and multiparameter flow cytometryCytometry Part B: Clinical Cytometry, 2007
- Quantitative analysis of the expression of glycosylphosphatidylinositol‐anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrowCytometry Part B: Clinical Cytometry, 2006
- Normal patterns of expression of glycosylphosphatidylinositol‐anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuriaCytometry Part B: Clinical Cytometry, 2006
- Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemiaBlood, 2006
- Clinical evaluation of an aerolysin‐based screening test for paroxysmal nocturnal haemoglobinuriaCytometry Part B: Clinical Cytometry, 2005
- CD157, the Janus of CD38 but with a unique personalityCell Biochemistry and Function, 2002
- Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuriaCytometry, 2000
- Pancreatic Islet Cells Express BST-1, a CD38-like Surface Molecule Having ADP-Ribosyl Cyclase ActivityBiochemical and Biophysical Research Communications, 1996